Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma

OBJECTIVE: To explore the efficacy and safety of gemcitabine (GEM) combined with cisplatin (DDP) in the treatment of recurrent/metastatic nasopharyngeal carcinoma (NPC). METHODS: A total of 100 patients with recurrent/metastatic NPC treated in the First Affiliated Hospital, Hengyang Medical School,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiao, Nie, Yue Hua, Cai, Man Bo, Li, Zhi Min, Zhu, Hong Bo, Tan, Ye Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056024/
https://www.ncbi.nlm.nih.gov/pubmed/35502425
http://dx.doi.org/10.2147/DDDT.S353898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056024/
https://www.ncbi.nlm.nih.gov/pubmed/35502425
http://dx.doi.org/10.2147/DDDT.S353898

Ejemplares similares